Predicting metastasized seminoma using gene expression

BJU International

Volumn 110, Issue , 2012, Pages

  Ruf, Christian G ^a,e   Linbecker, Michael ^a   Port, Matthias ^b   Riecke, Armin ^c,e   Schmelz, Hans U ^d   Wagner, Walter ^a   Meineke, Victor ^e   Abend, Michael ^e  

^a Bundeswehrkrankenhaus Hamburg   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c BUNDESWEHRKRANKENHAUS ULM   (Germany)

^d BUNDESWEHRZENTRALKRANKENHAUS KOBLENZ   (Germany)

^e Bundeswehr Institute of Radiobiology   (Germany)

Author keywords

gene expression; metastasized seminoma; primary tumour size; rete testis; testis tumour

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; COMPLEMENTARY DNA; DOPAMINE 1 RECEPTOR; GLUCOSE TRANSPORTER 3; RNA;

ACE2 GENE; ADULT; ALG12 GENE; ARTICLE; ATP9A GENE; CANCER INFILTRATION; CANCER INVASION; CANCER STAGING; CHROMOSOME 19; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPAMINE RECEPTOR D1 GENE; DZIP1L GENE; EF HAND DOMAIN CONTAINING 2 GENE; FALSE POSITIVE RESULT; FAMILY WITH SEQUENCE SIMILARITY 71 MEMBER F2 GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MBNL3 GENE; METASTASIS; MUM1L1 GENE; ONCOGENE; OPEN READING FRAME; PREDICTION; PREDICTIVE VALUE; PRF1 GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SAMD4B GENE; SEMINOMA; SENSITIVITY AND SPECIFICITY; SLC2A3 GENE; SMOC1 GENE; SP4 GENE; SPINLW1 GENE; TAF7L GENE; TUMOR VOLUME; UBOX5 GENE;

ADULT; GENE EXPRESSION PROFILING; GENES, NEOPLASM; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROTEINS; RECEPTORS, DOPAMINE D1; RETE TESTIS; SEMINOMA; TESTICULAR NEOPLASMS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84863538027     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10778.x     Document Type: Article

References (23)

1. Krege S, Beyer J, Souchon R, et al,. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008; 53: 478-96
2. Warde P, Specht L, Horwich A, et al,. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 2002; 20: 4448-52
3. Valdevenito JP, Gallegos I, Fernández C, Acevedo C, Palma R,. Correlation between primary tumor pathologic features and presence of clinical metastasis at diagnosis of testicular seminoma. Urology 2007; 70: 777-80
4. Warde P, Gospodarowicz MK, Banerjee D, et al,. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance. J Urol 1997; 157: 1705-10
5. Krege S, Souchon R, Schmoll HJ,. Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors: result of an update conference on evidence based medicine (EBM). Eur Urol 2001; 40: 372-91
6. Christofori G,. New signals from the invasive front. Nature 2006; 441: 444-50
7. Nicolson GL,. Gene expression, cellular diversification and tumor progression to the metastatic phenotype. Bioessays 1991; 13: 337-42
8. Mishina M, Ogawa O, Kinoshita H, et al,. Equivalent parental distribution of frequently lost alleles and biallelic expression of the H19 gene in human testicular germ cell tumors. Jpn J Cancer Res 1996; 87: 816-23
9. Port M, Wang Y, Schmelz HU, et al,. A gene signature of primary tumor identifies metastasized seminoma. Urol Oncol 2011; 6: 764-73
10. Port M, Schmelz HU, Stassen T, et al,. Correcting false gene expression measurements from degraded RNA using RTQ-PCR. Diagn Mol Pathol 2007; 16: 38-49
11. Hemmings HC Jr, Greengard P, Tung HY, et al,. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 1984; 310: 503-5
12. Yan Z, Hsieh-Wilson L, Feng J, et al,. Protein phosphatase 1 modulation of neostriatal AMPA channels: regulation by DARPP-32 and spinophilin. Nat Neurosci 1999; 2: 13-7
13. Li L, Miyamoto M, Ebihara Y, et al,. DRD2/DARPP-32 expression correlates with lymph node metastasis and tumor progression in patients with esophageal squamous cell carcinoma. World J Surg 2006; 30: 1672-9
14. Picardo M, Passi S, Nazzaro-Porro M, et al,. Mechanism of antitumoral activity of catechols in culture. Biochem Pharmacol 1987; 36: 417-25
15. Wick MM,. Levodopa/dopamine analogs as inhibitors of DNA synthesis in human melanoma cells. J Invest Dermatol 1989; 92: 329-31
16. Johnson DE, Ochieng J, Evans SL,. The growth inhibitory properties of a dopamine agonist (SKF 38393) on MCF-7 cells. Anticancer Drugs 1995; 6: 471-4
17. Zagars GK,. Stage I testicular seminoma following orchidectomy-to treat or not to treat. Eur J Cancer 1993; 29A: 1923-4
18. Horwich A, Alsanjari N, A'Hern R, Nicholls J, Dearnaley DP, Fisher C,. Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer 1992; 65: 775-8
19. von der Maase H, Specht L, Jacobsen GK, et al,. Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer 1993; 29A: 1931-4
20. Chung PW, Daugaard G, Tyldesley S, et al,. Prognostic factors for relapse in stage I seminoma managed with surveillance: a validation study. J Clin Oncol 2010; 28 (Suppl.): 15s (abstract 4535)
21. Weissbach L, Bussar-Maatz R, Löhrs U, et al,. Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group. Eur Urol 1999; 36: 601-8
22. Schmoll HJ, Souchon R, Krege S, et al,. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377-99
23. Port M, Schmelz HU, Stockinger M, et al,. Gene expression profiling in seminoma and nonseminoma. J Clin Oncol 2005; 23: 58-69